Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE3
A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE2
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Identifying Characteristics of Bone Marrow Failure Syndromes
- Status
- UNKNOWN
- Phase
- N/A
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
- Status
- TERMINATED
- Phase
- PHASE2